Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 1
1980 3
1981 2
1983 3
1984 2
1985 3
1986 3
1987 6
1988 2
1989 8
1990 8
1991 7
1992 6
1993 10
1994 7
1995 9
1996 9
1997 7
1998 11
1999 7
2000 7
2001 9
2002 12
2003 14
2004 8
2005 7
2006 6
2007 8
2008 13
2009 21
2010 16
2011 19
2012 19
2013 23
2014 28
2015 22
2016 15
2017 25
2018 29
2019 15
2020 20
2021 30
2022 27
2023 25
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

490 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and Treatment of Aplastic Anemia.
Peslak SA, Olson T, Babushok DV. Peslak SA, et al. Curr Treat Options Oncol. 2017 Nov 16;18(12):70. doi: 10.1007/s11864-017-0511-z. Curr Treat Options Oncol. 2017. PMID: 29143887 Free PMC article. Review.
The choice of frontline therapy is determined by a number of factors including AA severity, age of the patient, donor availability, and access to optimal therapies. For newly diagnosed severe aplastic anemia, bone marrow transplant should be pursued in all pe …
The choice of frontline therapy is determined by a number of factors including AA severity, age of the patient, donor availability, and acce …
Acquired aplastic anemia in children.
Hartung HD, Olson TS, Bessler M. Hartung HD, et al. Pediatr Clin North Am. 2013 Dec;60(6):1311-36. doi: 10.1016/j.pcl.2013.08.011. Epub 2013 Oct 16. Pediatr Clin North Am. 2013. PMID: 24237973 Free PMC article. Review.
Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.
Georges GE, Doney K, Storb R. Georges GE, et al. Blood Adv. 2018 Aug 14;2(15):2020-2028. doi: 10.1182/bloodadvances.2018021162. Blood Adv. 2018. PMID: 30108110 Free PMC article. Review.
Treatment of severe aplastic anemia has improved significantly over the past 4 decades. ...Implementation of this first-line treatment strategy will provide patients with severe aplastic anemia the best chance of long-term disease-free su …
Treatment of severe aplastic anemia has improved significantly over the past 4 decades. ...Implementation of this first …
How I treat acquired aplastic anemia.
Bacigalupo A. Bacigalupo A. Blood. 2017 Mar 16;129(11):1428-1436. doi: 10.1182/blood-2016-08-693481. Epub 2017 Jan 17. Blood. 2017. PMID: 28096088 Free article. Review.
Acquired severe aplastic anemia (SAA) is a rare hematologic disease associated with significant morbidity and mortality. ...
Acquired severe aplastic anemia (SAA) is a rare hematologic disease associated with significant morbidity and mortality …
How I treat myelodysplastic syndromes of childhood.
Locatelli F, Strahm B. Locatelli F, et al. Blood. 2018 Mar 29;131(13):1406-1414. doi: 10.1182/blood-2017-09-765214. Epub 2018 Feb 8. Blood. 2018. PMID: 29438960 Free article. Review.
Immune-suppressive therapy may be a treatment option for RCC patients with hypocellular bone marrow and the absence of monosomy 7 or a complex karyotype, although the response rate is lower than that observed in severe aplastic anemia, and a relevant proporti …
Immune-suppressive therapy may be a treatment option for RCC patients with hypocellular bone marrow and the absence of monosomy 7 or a compl …
Diagnostic work-up for severe aplastic anemia in children: Consensus of the North American Pediatric Aplastic Anemia Consortium.
Shimano KA, Narla A, Rose MJ, Gloude NJ, Allen SW, Bergstrom K, Broglie L, Carella BA, Castillo P, de Jong JLO, Dror Y, Geddis AE, Huang JN, Lau BW, McGuinn C, Nakano TA, Overholt K, Rothman JA, Sharathkumar A, Shereck E, Vlachos A, Olson TS, Bertuch AA, Wlodarski MW, Shimamura A, Boklan J. Shimano KA, et al. Am J Hematol. 2021 Nov 1;96(11):1491-1504. doi: 10.1002/ajh.26310. Epub 2021 Aug 20. Am J Hematol. 2021. PMID: 34342889 Free article.
This document outlines the rationale for initial evaluations in pediatric patients presenting with signs and symptoms concerning for severe aplastic anemia....
This document outlines the rationale for initial evaluations in pediatric patients presenting with signs and symptoms concerning for seve …
Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes.
McReynolds LJ, Rafati M, Wang Y, Ballew BJ, Kim J, Williams VV, Zhou W, Hendricks RM, Dagnall C, Freedman ND, Carter B, Strollo S, Hicks B, Zhu B, Jones K, Paczesny S, Marsh SGE, Spellman SR, He M, Wang T, Lee SJ, Savage SA, Gadalla SM. McReynolds LJ, et al. Blood. 2022 Aug 25;140(8):909-921. doi: 10.1182/blood.2022016508. Blood. 2022. PMID: 35776903 Free PMC article.
Patients with severe aplastic anemia (SAA) can have an unrecognized inherited bone marrow failure syndrome (IBMFS) because of phenotypic heterogeneity. ...
Patients with severe aplastic anemia (SAA) can have an unrecognized inherited bone marrow failure syndrome (IBMFS) beca …
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
Bejanyan N, Kim S, Hebert KM, Kekre N, Abdel-Azim H, Ahmed I, Aljurf M, Badawy SM, Beitinjaneh A, Boelens JJ, Diaz MA, Dvorak CC, Gadalla S, Gajewski J, Gale RP, Ganguly S, Gennery AR, George B, Gergis U, Gómez-Almaguer D, Vicent MG, Hashem H, Kamble RT, Kasow KA, Lazarus HM, Mathews V, Orchard PJ, Pulsipher M, Ringden O, Schultz K, Teira P, Woolfrey AE, Saldaña BD, Savani B, Winiarski J, Yared J, Weisdorf DJ, Antin JH, Eapen M. Bejanyan N, et al. Blood Adv. 2019 Oct 22;3(20):3123-3131. doi: 10.1182/bloodadvances.2019000722. Blood Adv. 2019. PMID: 31648332 Free PMC article.
Allogeneic bone marrow transplantation (BMT) is curative therapy for the treatment of patients with severe aplastic anemia (SAA). However, several conditioning regimens can be used for BMT. ...
Allogeneic bone marrow transplantation (BMT) is curative therapy for the treatment of patients with severe aplastic anemia …
New-onset aplastic anemia after SARS-CoV-2 vaccination.
Chatzikalil E, Kattamis A, Diamantopoulos P, Solomou EE. Chatzikalil E, et al. Int J Hematol. 2023 Dec;118(6):667-681. doi: 10.1007/s12185-023-03666-z. Epub 2023 Sep 28. Int J Hematol. 2023. PMID: 37768509 Review.
The time from vaccination to onset of aplastic anemia ranged from 1 day to 7 months, with a median of 2.5 weeks. Seventeen patients were diagnosed with severe or very severe aplastic anemia post-vaccination and all patients received standard treatments for ac …
The time from vaccination to onset of aplastic anemia ranged from 1 day to 7 months, with a median of 2.5 weeks. Seventeen patients were dia …
Idiopathic aplastic anemia: diagnosis and classification.
Dolberg OJ, Levy Y. Dolberg OJ, et al. Autoimmun Rev. 2014 Apr-May;13(4-5):569-73. doi: 10.1016/j.autrev.2014.01.014. Epub 2014 Jan 12. Autoimmun Rev. 2014. PMID: 24424170 Review.
The pathogenesis of AA is complex and involves an abnormal hematopoietic microenvironment, hematopoietic stem cell/progenitor cell deficiencies and immunity disorders. Survival in severe aplastic anemia (SAA) has markedly improved in the past 4 decades becaus …
The pathogenesis of AA is complex and involves an abnormal hematopoietic microenvironment, hematopoietic stem cell/progenitor cell deficienc …
490 results